Literature DB >> 2744860

Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age.

P M Martin1, J Mathiot, J Ipero, M Kirimat, A J Georges, M C Georges-Courbot.   

Abstract

A cohort of 111 children from Bangui, Central African Republic, was surveyed for enteric Campylobacter infections from birth to the age of 2 years; stools were examined biweekly in these children until 6 months of age and at least four times per year thereafter until 2 years of age and after each diarrheal episode. Blood samples were obtained at birth and at 3, 6, 9, 12, 18, and 24 months of age. Antibodies against glycine-extracted membrane antigens, purified flagella, and cholera toxin (CT) were assayed by an enzyme-linked immunosorbent assay. The results showed that titers of antibody against the three tested antigens increased in children between 6 and 12 months of age and that nearly all children were immunized by the age of 2 years. A significant fall in anti-flagellum (P less than 0.001) and anti-glycine extract antibodies (P less than 0.001) occurred between birth and age 3 months, and children who had Campylobacter infections during the first 6 months of life had significantly (P less than 0.02) less anti-flagellum antibodies at birth than did those who did not have Campylobacter infections during that time. Three-month-interval stratification showed that CT antibody titers at birth were significantly lower in children who developed Campylobacter infection than in controls (P = 0.05). Comparison of the immune response to a single Campylobacter episode showed that 46.6% of children with asymptomatic carriage did not respond to CT while only 5% of children with diarrhea-producing infection did not respond to CT (P less than 0.01), compared with 30% (P = 0.065) and 56% (P less than 0.01), respectively, of the age-matched controls. Antibodies to flagella seem to protect against enteric colonization by Campylobacter jejuni and Campylobacter coli.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744860      PMCID: PMC313483          DOI: 10.1128/iai.57.8.2542-2546.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Campylobacter enteritis.

Authors:  M J Blaser; L B Reller
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

4.  Campylobacter enteritis in The Gambia.

Authors:  J D Billingham
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

5.  Epidemiologic and clinical features of endemic Campylobacter jejuni infection in Bangladesh.

Authors:  R I Glass; B J Stoll; M I Huq; M J Struelens; M Blaser; A K Kibriya
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

6.  Serologic study of two clusters of infection due to Campylobacter jejuni.

Authors:  M J Blaser; D J Duncan; M T Osterholm; G R Istre; W L Wang
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

7.  Detection of enteric campylobacteriosis in children.

Authors:  V D Bokkenheuser; N J Richardson; J H Bryner; D J Roux; A B Schutte; H J Koornhof; I Freiman; E Hartman
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

8.  Enteropathogenic agents in children with diarrhoea in rural Zaire.

Authors:  P de Mol; D Brasseur; W Hemelhof; T Kalala; J P Butzler; H L Vis
Journal:  Lancet       Date:  1983-03-05       Impact factor: 79.321

9.  Experimental infection of Rhesus monkeys with a human strain of Campylobacter jejuni.

Authors:  R B Fitzgeorge; A Baskerville; K P Lander
Journal:  J Hyg (Lond)       Date:  1981-06

10.  Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children.

Authors:  M J Blaser; R I Glass; M I Huq; B Stoll; G M Kibriya; A R Alim
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

View more
  20 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, Turkey.

Authors:  C K Porter; H El Mohammady; S Baqar; D M Rockabrand; S D Putnam; D R Tribble; M S Riddle; R W Frenck; P Rozmajzl; E Kilbane; A Fox; R Ruck; M Lim; Y J Johnston; E Murphy; J W Sanders
Journal:  Clin Vaccine Immunol       Date:  2008-10-08

3.  Restriction fragment length polymorphism of flagellin genes of Campylobacter jejuni and/or C. coli isolates from Egypt.

Authors:  Z S Mohran; P Guerry; H Lior; J R Murphy; A M el-Gendy; M M Mikhail; B A Oyofo
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Significance of flagella in colonization resistance of rabbits immunized with Campylobacter spp.

Authors:  O R Pavlovskis; D M Rollins; R L Haberberger; A E Green; L Habash; S Strocko; R I Walker
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

5.  Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni.

Authors:  L H Lee; E Burg; S Baqar; A L Bourgeois; D H Burr; C P Ewing; T J Trust; P Guerry
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

7.  Development and characterization of recA mutants of Campylobacter jejuni for inclusion in attenuated vaccines.

Authors:  P Guerry; P M Pope; D H Burr; J Leifer; S W Joseph; A L Bourgeois
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 8.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

Review 9.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk.

Authors:  I Nachamkin; S H Fischer; X H Yang; O Benitez; A Cravioto
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.